1. Another attack on Indian generic Pharmaceutical sector? The U.S. drug regulator, FDA has now sent a “warning letter” to Indian pharma company L

1. Another attack on Indian generic Pharmaceutical sector? The U.S. drug regulator, FDA has now sent a “warning letter” to Indian pharma company L